BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 17461310)

  • 1. Clinical outcome after D1 vs D2-3 gastrectomy for treatment of gastric cancer.
    Danielson H; Kokkola A; Kiviluoto T; Sirén J; Louhimo J; Kivilaakso E; Puolakkainen P
    Scand J Surg; 2007; 96(1):35-40. PubMed ID: 17461310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study.
    Rausei S; Ruspi L; Rosa F; Morgagni P; Marrelli D; Cossu A; Cananzi FC; Lomonaco R; Coniglio A; Biondi A; Cipollari C; Graziosi L; Fumagalli U; Casella F; Bertoli P; di Leo A; Alfieri S; Vittimberga G; Roviello F; Orsenigo E; Quagliuolo V; Montemurro S; Baiocchi G; Persiani R; Bencivenga M; Donini A; Rosati R; Sansonetti A; Ansaloni L; Zanoni A; Galli F; Dionigi G;
    Eur J Surg Oncol; 2016 Dec; 42(12):1881-1889. PubMed ID: 27266816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical outcomes of gastrectomy with D1 lymph node dissection performed for patients with unfavorable clinical conditions.
    Ramos MFKP; Pereira MA; Dias AR; Yagi OK; Zaidan EP; Ribeiro-Júnior U; Zilberstein B; Cecconello I
    Eur J Surg Oncol; 2019 Mar; 45(3):460-465. PubMed ID: 30497814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal extent of lymphadenectomy for gastric adenocarcinoma: A 7-institution study of the U.S. gastric cancer collaborative.
    Randle RW; Swords DS; Levine EA; Fino NF; Squires MH; Poultsides G; Fields RC; Bloomston M; Weber SM; Pawlik TM; Jin LX; Spolverato G; Schmidt C; Worhunsky D; Cho CS; Maithel SK; Votanopoulos KI
    J Surg Oncol; 2016 Jun; 113(7):750-5. PubMed ID: 26996496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
    Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
    Anticancer Res; 2000; 20(2B):1285-9. PubMed ID: 10810436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma.
    Memon MA; Subramanya MS; Khan S; Hossain MB; Osland E; Memon B
    Ann Surg; 2011 May; 253(5):900-11. PubMed ID: 21394009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.
    Songun I; Putter H; Kranenbarg EM; Sasako M; van de Velde CJ
    Lancet Oncol; 2010 May; 11(5):439-49. PubMed ID: 20409751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
    Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
    J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].
    Di Martino N; Izzo G; Cosenza A; Vicenzo L; Monaco L; Torelli F; Basciotti A; Brillantino A; Marra A
    Suppl Tumori; 2005; 4(3):S84-5. PubMed ID: 16437920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
    Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
    Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group.
    Cuschieri A; Fayers P; Fielding J; Craven J; Bancewicz J; Joypaul V; Cook P
    Lancet; 1996 Apr; 347(9007):995-9. PubMed ID: 8606613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications of gastrectomy with lymphadenectomy in gastric cancer.
    Zilberstein B; Martins BC; Jacob CE; Bresciani C; Lopasso FP; de Cleva R; Pinto Junior PE; Junior UR; Perez RO; Gama-Rodrigues J
    Gastric Cancer; 2004; 7(4):254-9. PubMed ID: 15616774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis.
    Galizia G; Lieto E; De Vita F; Castellano P; Ferraraccio F; Zamboli A; Mabilia A; Auricchio A; De Sena G; De Stefano L; Cardella F; Barbarisi A; Orditura M
    Surgery; 2015 Feb; 157(2):285-96. PubMed ID: 25532433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D2 lymphadenectomy for gastric cancer in Tata Memorial Hospital: Indian data can now be incorporated in future international trials.
    Shrikhande SV; Shukla PJ; Qureshi S; Siddachari R; Upasani V; Ramadwar M; Kakade AC; Hawaldar R
    Dig Surg; 2006; 23(3):192-7. PubMed ID: 16837811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of D1 and D2 ganglionic dissection in advanced gastric cancer at Rebagliati Hospital].
    Cornejo C; Portanova M
    Rev Gastroenterol Peru; 2006; 26(4):351-6. PubMed ID: 17211484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer.
    Degiuli M; Sasako M; Ponti A; Vendrame A; Tomatis M; Mazza C; Borasi A; Capussotti L; Fronda G; Morino M;
    Br J Surg; 2014 Jan; 101(2):23-31. PubMed ID: 24375296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative adjuvant treatment for gastric cancer improves long-term survival after curative resection and D2 lymphadenectomy. Results from a Latin American Center.
    Norero E; Bustos M; Herrera ME; Cerda J; González P; Ceroni M; Martínez C; Briceño E; Rojas H; Cártes R; Lopez V; Hidalgo V; Báez S; Caracci M; Viñuela E; Díaz A
    Eur J Surg Oncol; 2016 Jan; 42(1):94-102. PubMed ID: 26577767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D1 versus D2 Gastrectomy for Gastric Adenocarcinoma.
    Lavy R; Hershkovitz Y; Chikman B; Shapira Z; Poluksht N; Yarom N; Sandbank J; Halevy A
    Isr Med Assoc J; 2015 Dec; 17(12):735-8. PubMed ID: 26897973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified radical lymphadenectomy (D1.5) for T2-3 gastric cancer.
    Ichikura T; Chochi K; Sugasawa H; Mochizuki H
    Langenbecks Arch Surg; 2005 Sep; 390(5):397-402. PubMed ID: 16041552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival benefit of extended D2 resection for proximal gastric cancer.
    Volpe CM; Driscoll DL; Miloro SM; Douglass HO
    J Surg Oncol; 1997 Mar; 64(3):231-6. PubMed ID: 9121155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.